Registering new brain tumor patients to build better care
Part of Brain & nervous system, Cancer clinical trials.
This study collects medical information (and sometimes tumor tissue) from people diagnosed with certain brain tumors after January 1, 2012. It aims to improve understanding of these tumors worldwide so future care can be better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a diagnosis included in the study’s brain-tumor list (with a few specific exceptions)
- Your new diagnosis happened on or after January 1, 2012
- You agree to provide information and allow transfer of your data (and tumor samples if applicable) to researchers
- Your local/national ethics committee approves participation where you live
- You are not already registered in another clinical trial for the same diagnosis
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at “brain biomarkers,” meaning brain signals measured on MRI and thinking/learning tests on a computer. It may help researchers understand how brain tumors affect the brain and track changes over time.
This is an observational study that collects and compares information from patients with primary brain tumors and their treatment results. It uses stored tumor tissue and brain scans to better understand outcomes using updated tumor classification methods.
This study creates an international registry linked to a virtual biobank, so researchers can collect and share information and biological samples for patients with specific peripheral neuroblastic tumors. It may help future research and care planning by improving what scientists know about these conditions.
This study builds a large medical database of people with primary brain or spinal cord tumors treated at the Montpellier Cancer Institute. It may help researchers understand patterns of care and outcomes, which can guide future research and treatment decisions.
This study collects information about people with brain gliomas, including what treatments they receive and what their brain scans show. It’s meant to help researchers better understand these tumors and how they respond to first- or second-line therapy.
This study looks at genetic (DNA/molecular) features of malignant brain tumors in children. It may help doctors better understand tumor risk patterns and guide future treatment planning.
Hear when a new Childhood Brain Tumor trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.